U.S. Markets close in 5 hrs 47 mins

AorTech International plc (AOR.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
11.500.00 (0.00%)
As of 4:30PM BST. Market open.
People also watch

AorTech International plc

Springfield House
Level Two
Weybridge KT13 9LZ
United Kingdom


Full Time Employees3

Key Executives

Mr. William Donald BrownChairman and Fin. Director60.03kN/A53
Mr. Gregg ChiponisVP of Operations & QualityN/AN/AN/A
Mr. Ajay Padsalgikar Ph.D.Chief Scientific OfficerN/AN/AN/A
Mr. David J. C. Parsons ACISCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


AorTech International Plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. Its product portfolio includes Elast-Eon, a bio stable polyurethane material used in long term implantation; Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance; and Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. The company licenses its technology to medical device companies. AorTech International Plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.

Corporate Governance

AorTech International plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.